When Alexion Pharmaceuticals announced in 2016 that it was moving back to New Haven after nearly a decade in Cheshire, elected officials and civic leaders hailed the news as a sign that the Elm City was fast becoming a force in biomedical research.Supported by more than $50 million in grants, loans and tax breaks from Gov.